Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
-
Brunswick Corporation Makes Further Significant Gains at Cannes Boat Show
-
HighPeak Energy, Inc. Announces CEO Transition
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UNITE GROUP PLC/THE - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RICARDO PLC - Ordinary Shares
-
The New Rules of the College Essay in the Age of AI: Authenticity, Empathy, and Service Learning
-
Transactions in connection with share buyback programme
-
ITM to Present COMPETE Dosimetry Data and Host Satellite Symposium at EANM 2025
-
Riviera Partners acquires Board and Technology (BaT) and welcomes Olof Pripp as Partner, Expanding Global Reach and Boardroom Expertise
-
Indicium Receives Investment from Databricks Ventures
-
Riviera Partners acquires Board and Technology (BaT) and welcomes Olof Pripp as Partner, Expanding Global Reach and Boardroom Expertise
-
MEDIA RELEASE: Oritain Expands into Timber through Strategic Partnership with World Forest ID
-
Aicuris Announces Upcoming Oral and Poster Presentations at ID Week 2025
-
NUCLIDIUM to Present Clinical Data from Phase I/II Study for Copper-based PET-Diagnostic in Neuroendocrine Tumors at EANM 2025
-
Osivax Announces First Participant Vaccinated in Phase 2b Trial Evaluating Broad-Spectrum Influenza A Vaccine Candidate, OVX836
-
Hidden Threats, Local Impact: New Industry Survey Finds U.S. Mid-size and Community Banks on the Front Lines of Rising Financial Crime
-
Quantexa Launches Cloud AML Product for U.S. Mid-size and Community Banks
-
Italfarmaco Announces Exclusive Distribution Agreement with Multicare Pharma for DMD Treatment Givinostat in Brazil
-
Manchester charity recognises UK hero volunteers
-
Interim report Q3 2024/25
-
Directed share issue
-
Rovsing A/S releases its Annual Report 2024/25
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
GlobalFoundries Joins World Economic Forum’s Global Lighthouse Network for Manufacturing Excellence
-
Ghent University spin-off OnTracx raises €1.2M to help runners recover and stay injury-free
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
New Imprivata Report Finds that UK Hospitals Save More Than £522K Annually with Shared-Use Mobile Devices, but Gaps in Strategy Pose Risks
-
Cumulus Oncology Strengthens Board of Directors & Scientific Advisory Team
-
Cumulus Oncology Strengthens Board of Directors & Scientific Advisory Team
-
Kaldvik AS - Last day of the subscription period in the subsequent offering
-
Form 8.5 (EPT/RI) - Dowlais Group plc
-
Form 8.5 (EPT/RI) - NCC Group plc
-
Form 8.5 (EPT/RI) - Ricardo PLC
-
Form 8.5 (EPT/RI) - Treatt plc
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Karolinska Development’s portfolio company AnaCardio completes patient recruitment in phase 2a study of its drug candidate AC01
-
Harvia Introduces Fenix and updated smart sauna app – Intuitive Sauna Control for a Connected Future
-
Is this the future of travel? Copenhagen nudges 70% of tourists to change daily habits
-
InterLAN supercharges network across Europe with Nokia’s advanced IP routing solutions
-
Payhawk transforms spending experience for businesses with four enterprise-ready AI agents
-
Municipality Finance issues a NOK 1 billion tap under its MTN programme
-
After U.K. and Australia, New Zealand Removes Igor Makarov from Sanctions List
-
Moody's affirms Artea Bank ratings and its stable outlook
-
Nedap enables mobile credentials in Google Wallet
-
Solomon Global Announced as Headline Sponsor of the London Investor Show 2025
-
Cantoni Therapeutics secures financing to advance novel non-incretin obesity drug into IND enabling phase
-
Valeo is renewing its employee share offering
-
Cantoni Therapeutics secures financing to advance novel non-incretin obesity drug into IND enabling phase
-
WENDEL: Management of the Exchangeable Bond maturing in 2026: successful completion of the accelerated placement of approximately 23 million Bureau Veritas shares
-
Equinor ASA: Share buy-back – third tranche for 2025
